Disclaimer: This is a user generated content submitted by a member of the WriteUpCafe Community. The views and writings here reflect that of the author and not of WriteUpCafe. If you have any complaints regarding this post kindly report it to us.

Healthcare providers use the drug Erlotinib which the FDA approved in 2004, to treat patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic pancreatic cancer. Erlotinib tablets are present in 100 mg and 150 mg strengths to administer orally. The active ingredient in the tablet is Erlotinib hydrochloride, and the inactive ingredients are lactose monohydrate, hypromellose, hydroxypropyl cellulose, magnesium stearate, microcrystalline cellulose, sodium starch glycolate, sodium lauryl sulfate, and titanium dioxide. Erlotinib hydrochloride is slightly soluble in water, slightly soluble in methanol, and practically insoluble in acetonitrile, acetone, ethyl acetate, and hexane. One should store this medicine at 25°C (77°F); excursions are permitted to 15°C – 30°C or 59°F – 86°F.

Erlotinib price is economical, and one can find this medication with certified generic drug suppliers. For more details about Erlotinib, please ring us on 18008891064.



Welcome to WriteUpCafe Community

Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe